CS1P1 PET Studies of Neuroinflammation in Parkinson Disease
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Washington University School of Medicine
- Study ID
- NCT06084533
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- [11C]-CS1P1 — DRUGParticipants will receive a single intravenous bolus injection of 10.0 - 20.0 milliCurie (mCi) of the investigational radiotracer \[11C\]-CS1P1. Participants will then undergo a \[11C\]-CS1P1 PET scan.
Study Details
Parkinson disease (PD) is a progressive neurological disorder strongly linked to advancing age that results in decline in mobility and thinking. Based on prior research, the investigators think that small amounts of inflammation in the brain may contribute to the mobility and thinking problems in people with PD. They are trying to measure inflammation in the brain in order to understand how this inflammation could be contributing to the symptoms of PD. This study involves a brain positron emission tomography (PET) scan with a new, investigational radioactive tracer called \[11C\]-CS1P1 to identify inflammation in the brain.The goal of this project is to quantify neuroinflammation with \[11C\]-CS1P1 PET and compare to motor and cognitive function in participants with various stages of severity of PD compared to controls.
Key Dates
- Start date
- Jan 10, 2024
- Status verified
- Mar 2026
- Primary completion
- Feb 1, 2029
- Completion
- Feb 28, 2029
Study Design
- Enrollment
- 80 participants (estimated)
Arms
- Arm: Parkinson Disease
- Arm: Healthy Control
Primary Outcome Measure
PET imaging studies of [11C]-CS1P1 in healthy control participants and participants with Parkinson Disease. [ Time Frame: At the time of PET scan ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Washington University School of Medicine | St Louis | Missouri | 63105 | - |
Find similar trials in St Louis, MO
Related Studies
- North American Prodromal Synucleinopathy ConsortiumEnrolling By Invitation · Washington University School of Medicine · Sun City, Arizona
- Clinical Outcomes for Deep Brain StimulationRecruiting · Washington University School of Medicine · St Louis, Missouri
- Study in Parkinson Disease of ExerciseRecruiting · Northwestern University · Birmingham, Alabama
- North American Prodromal Synucleinopathy Consortium Stage 2Enrolling By Invitation · Washington University School of Medicine · Los Angeles, California